<DOC>
	<DOCNO>NCT00782990</DOCNO>
	<brief_summary>Objective : To compare TVT COLPOSUSPENSION ( CS ) primary treatment stress incontinence ( SUI ) . Design : Randomised , open , comparative trial 3-years follow-up . Participants : 49 consecutive 35 70 year old woman urodynamic SUI . Setting : Urology department district general hospital Leganés ( Madrid ) , Spain . Intervention : 24 patient randomise TVT 25 CS .</brief_summary>
	<brief_title>A 3 Year Follow-up Prospective Open Randomized Trial TVT Versus Colposuspension Primary Stress Incontinence</brief_title>
	<detailed_description>Background : Evidence compare effectiveness tension-free vaginal tape ( TVT ) Burch 's colposuspension ( CS ) long term follow-up weak . Objective : To compare TVT CS primary treatment stress incontinence ( SUI ) . Design : Randomised , open , comparative trial 3-years follow-up . Participants : 49 consecutive 35 70 year old woman urodynamic SUI . Setting : Urology department district general hospital Leganés ( Madrid ) , Spain . Intervention : 24 patient randomise TVT 25 CS . Measurements : Main outcome : Assessment treatment 6-months , 1-year 3-years postoperatively incontinence severity symptom index ( ISS ) incontinence impact symptom index ( IIS ) Secondary outcome : 3 group asses cure rate : cure , improved failure .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Women age 35 70 complete family clinical ( Booney test positive ) urodynamic diagnosis Stress Urinary Incontinence Previous surgery prolapse , incontinence bladder disease , urodynamic diagnosis detrusor overactivity , void difficulty ( define maximum flow less 15 ml/second voiding pressure great 50 cm H2O residual volume great 100 ml ) Cystocele grade I Previous hysterectomy Body mass index ( BMI ) 40 Uncontrolled diabetes Neurological disease Recurrent urinary tract infection Genital atrophy preclude vaginal surgery Known bleed diathesis current anticoagulant therapy</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>stress urinary incontinence</keyword>
	<keyword>female incontinence</keyword>
	<keyword>surgical treatment</keyword>
	<keyword>Female stress urinary incontinence</keyword>
</DOC>